Serum Superoxide Dismutase as A Biomarker in Severe Traumatic Brain Injury: A Case-Control Study
Iranian Journal of Neurosurgery · 2024-01 · 10 (Continuous Publishing) · 188-195
DOI: 10.32598/irjns.10.22 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Iranian Journal of Neurosurgery, 2024-01. Verfasst von Sharad Pandey und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pandey, S., Chakraborty, S., Kumar, P., Sharma, N., Gupta, L. N., Mittal, A., & Saxena, A. (2024). Serum Superoxide Dismutase as A Biomarker in Severe Traumatic Brain Injury: A Case-Control Study. Iranian Journal of Neurosurgery, 10(Continuous Publishing), 188-195. https://doi.org/10.32598/irjns.10.22
Vancouver
Pandey S, Chakraborty S, Kumar P, Sharma N, Gupta LN, Mittal A, et al. Serum Superoxide Dismutase as A Biomarker in Severe Traumatic Brain Injury: A Case-Control Study. Iranian Journal of Neurosurgery. 2024;10(Continuous Publishing):188-195. doi:10.32598/irjns.10.22
BibTeX
@article{Pandey2024,
author = {Pandey, Sharad and Chakraborty, Sourabh and Kumar, Pankaj and Sharma, Neera and Gupta, L. N. and Mittal, Amol and Saxena, Achal},
title = {Serum Superoxide Dismutase as A Biomarker in Severe Traumatic Brain Injury: A Case-Control Study},
journal = {Iranian Journal of Neurosurgery},
year = {2024},
volume = {10},
number = {Continuous Publishing},
pages = {188--195},
doi = {10.32598/irjns.10.22}
}
EUVIMED